«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2024 23

Page:

4469-4476

Research Field:

Publishing date:

Info

Title:

Analysis of patent application and conversion and utilization in international specialized oncology hospitals from 2000-2023

Author(s):

XIAO Yufeng¹; YUAN Yakun¹; ZHANG Bin¹; DAI Min²; YAO Libo²

1.Institute of Medical Information/Library,Chinese Academy of Medical Sciences,Beijing 100005,China;2.National Cancer Center/National Clinical Research Center for Cancer/Scientific Research Department,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China.

Keywords:

international specialized tumor hospital; patent application; patent licensing; patent transfer; high value patents

PACS:

R73-31

DOI:

10.3969/j.issn.1672-4992.2024.23.008

Abstract:

Objective:To review the patent filing,granting,and transformation of first-class oncology speciality hospitals in China and the United States from 2000 to 2023,and to provide reference for the enhancement of hospitals' high-level intellectual property management and achievement transformation.Methods:The Incopat database was applied to collect and collate the patent filing trends,patent R&D layouts,high-value patent application hotspots,assignments/transformations of the University of Texas M.D.Anderson Cancer Center,Harvard Dana-Farber Cancer Institute,Sloan-Kettering Cancer Center,Cancer Hospital of the Chinese Academy of Medical Sciences,Cancer Prevention and Control Centre of Sun Yat-sen University,and Cancer Hospital of Fudan University from 2000 to 2023.Results:Although Anderson Cancer Center has a relatively small number of patent application disclosures,the quality of its patents is very high,with the percentage of high-value patents over 90% and the percentage of patent transfer and licensing nearly 50%.Dana-Farber Cancer Institute and Sloan Kettering Cancer Center both have a very clear advantage over other hospitals in terms of the total number of patent disclosures,with more than 1 500,the percentage of high-value patents between 60% and 80%,and the percentage of patent transfers between 7% and 10%.The number of invention patents disclosed by Sun Yat-sen University Cancer Prevention and Control Centre and Cancer Hospital of the Academy of Medical Sciences has been growing rapidly in recent years,with the total number of patents exceeding 500,and the proportion of high-value patents being around 60%,but the proportion of patents transformed is relatively low.The research hotspots of experts in US medical institutions all focus on novel compounds and biologics,while the applications of the three domestic medical institutions focus on medical devices.Conclusion:The number and percentage of high value of domestic hospitals are still far lower than that of the two U.S.hospitals.It is recommended that the state establish a patent classification and management system and build a patent interaction platform at the national level.Medical institutions can strengthen their management in various aspects,such as incubating high-quality patents,guiding and promoting patent transformation,strengthening intellectual property training,and enhancing international cooperation,so as to improve the quality of hospital patents and take a good transformation path.

References:

[1]HAN B,ZHENG R,ZENG H,et al.Cancer incidence and mortality in China,2022［J］.Journal of the National Cancer Center,2024:4(1):47-53.
[2]中共中央国务院.“健康中国2030”规划纲要［EB/OL］.(2016-10-25)［2024-08-10］.https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm?eqid=8f41987b002a7e4a000000026471aa44. The Central Committee of the CPC and the State Council.Outline of the "Healthy China 2030" Plan［EB/OL］.(2016-10-25)［2024-08-10］.https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm?eqid=8f41987b002a7e4a000000026471aa44.
[3]国家卫生健康委,国家发展改革委,教育部，等.关于印发健康中国行动-癌症防治行动实施方案（2023-2030年）的通知［EB/OL］.(2023-10-30)［2024-08-10］.https://www.gov.cn/zhengce/zhengceku/202311/content_6915380.htm. National Health Commission,National Development and Reform Commission,Ministry of Education,et al.Notice on issuing the implementation plan for the healthy China action-cancer prevention and control action(2023-2030)［EB/OL］.(2023-10-30)［2024-08-10］.https://www.gov.cn/zhengce/zhengceku/202311/content_6915380.htm.
[4]沈健.我国大学专利转化率过低的原因及对策研究［J］.科技管理研究,2021,41(5):97-103. SHEN J.Research on the causes and countermeasures of low technology transfer rate in Chinese universities［J］.Science and Technology Management Research,2021,41(5):97-103.
[5]中国医学科学院.医院肿瘤学2018-2022五年ASTEM［EB/OL］.(2023-7-6)［2024-08-10］.http://top100.imicams.ac.cn/ASTEM/hospital. Chinese Academy of Medical Sciences.Oncology ranking in hospital 2018-2022 five year ASTEM［EB/OL］.(2023-7-6)［2024-08-10］.http://top100.imicams.ac.cn/ASTEM/hospital.
[6]U.S.News.Best hospitals for cancer［EB/OL］.［2024-1-1］.https://health.usnews.com/best-hospitals/rankings/cancer.
[7]张敏,程蕾蕾,姜红,等.科研奖励机制在医学专利转化中的价值探讨［J］.中华医学科研管理杂志,2019,32(1):43-46. ZHANG M,CHENG LL,JIANG H,et al.The value of scientific research reward mechanism in the transformation of medical patent［J］.Chinese Journal of Medical Science Research Management,2019,32(1):43-46.
[8]JENSEN RA，THURSBYM C.Proofs and prototypes for sale：the licensing of university inventions ［J］.American Economic Review,2001,91(1)：240-259.
[9]戴瑞明,庄建辉.我国4家主要肿瘤专科医院的专利授权现状及对策［J］.中国卫生资源,2022,25(2):172-174,187. DAI RM,ZHUANG JH.The patent licensing status and countermeasures of four major cancer specialized hospitals in China［J］.Chinese Health Resources,2022,25(2):172-174,187.
[10]李国聪,樊培伟.公立医院科技成果转化问题的探析［J］.中国发明与专利,2020,17(9):68-72. LI GC,FAN PW.Analysis of the transformation of scientific and technological achievements in public hospitals［J］.China Invention & Patent,2020,17(9):68-72.
[11]国务院办公厅.关于印发《专利转化运用专项行动方案（2023-2025年）》的通知［EB/OL］.(2023-10-17)［2024-08-10］.https://www.gov.cn/zhengce/zhengceku/202310/content_6910282.htm. General Office of the State Council.The special action plan for patent conversion and application(2023-2025)［EB/OL］.(2023-10-17)［2024-08-10］.https://www.gov.cn/zhengce/zhengceku/202310/content_6910282.htm.
[12]国家知识产权局，教育部，科技部,等.关于印发《高校和科研机构存量专利盘活工作方案》的通知［EB/OL］.(2024-1-26)［2024-08-10］.https://www.gov.cn/zhengce/zhengceku/202402/content_6930439.htm. State Intellectual Property Office,Ministry of Education,Ministry of Science and Technology,et al.Notice on issuing work plan for revitalizing existing patents in iniversities and research institutions［EB/OL］.(2024-1-26)［2024-08-10］.https://www.gov.cn/zhengce/zhengceku/202402/content_6930439.htm.
[13]李浩,王有俊,孙心岩.医院专利及成果转化管理问题与对策［J］.中华医学科研管理杂志,2024,37(1):45-49. LI H,WANG YJ,SUN XY.Problems and countermeasures in the management of patent and achievement transformation in hospitals:Taking a national medical center as an example［J］.Chinese Journal of Medical Science Research Management,2024,37(1):45-49.
[14]吕媛媛,江之帆,朱婧,等.医疗机构科技成果转化过程中若干法律风险及规避措施［J］.中国医院,2024,28(2):79-82. LYU YY,JIANG ZF,ZHU J,et al.Legal risks and avoidance measures in the process of transformation of scientific and technological achievements of medical institutions［J］.Chinese Hospitals,2024,28(2):79-82.
[15]邵晶晶.北京市13家综合医院专利发展情况分析［J］.中华医院管理杂志,2023,39(1):32-37. SHAO JJ.Analysis on patent development at 13 general hospitals in Beijing［J］.Chinese Journal of Hospital Adminstration,2023,39(1):32-37.
[16]花倩,陈俊仰,朱梓嫣,等.多渠道推进医院专利转化探索研究［J］.中华医学科研管理杂志,2022,35(2):127-130. HUA Q,CHEN JY,ZHU ZY,et al.Promoting the exploration and research of hospital patent transformation through multiple channels［J］.Chinese Journal of Medical Science Research Management,2022,35(2):127-130.
[17]韩晓洁,兰玉坤,陈钊,等.医疗专利转化困境的成因与对策分析［J］.中华医学科研管理杂志,2018,31(1):24-28. HAN XJ,LAN YK,CHEN Z,et al.Analysis on the causes and countermeasures of the dilemma in medical patents transfer［J］.Chinese Journal of Medical Science Research Management,2018,31(1):24-28.

Memo

Memo:

北京协和医学院“中央高校基本科研业务费”（编号：3332023104）;中国医学科学院肿瘤医院管理研究课题（编号：LC2022D04）;中国工程科技知识中心建设项目全球工程科技前沿-医药卫生学部领域服务课题（编号：CKCEST-2023-1-15）

Common functions

Last Update: 2024-11-01